Center For Technology Licensing

IGNITE:Research Acceleration Webinar - Info Session 1
2021-04-09 12:00 - 13:00 UTC
IGNITE is Cornell Research’s next-generation funding program based on its original gap fund, the Cornell Technology Acceleration and Maturation (CTAM) Fund. The program provides up to $50,000 in grant funding to research labs. Projects are funded based on their alignment with the goals of the program.

During this virtual meeting, the team at CTL will provide information about the objectives of the program, the requirements to apply, and the selection process.

Register here:
https://cornell.zoom.us/meeting/register/tJMocOmgpjkrE9EJE9jWJp3zBPgGXge_Re6b

More information about IGNITE:Research Acceleration:
https://ctl.cornell.edu/inventors/ignite-program/research-acceleration/

Fruit & Vegetable Markets: COVID-19 Impacts and Beyond
2021-04-14 12:00 - 13:00 (America/New_York)
Join us for a panel discussion on the impacts of COVID-19 on the fruit and vegetable markets across the U.S.A. and specifically in New York State.

Panelists

Richard A. Ball, Commissioner, NYS Department of Agriculture & Markets
James E. Prevor, Founder and Editor-in-Chief, Produce Business
Bradley J. Rickard, Associate Professor of Food and Agricultural Economics in the Charles H. Dyson School of Applied Economics and Management

Moderator

Jess Stein, Senior Licensing and Business Development Officer at Cornell University.

Register

https://cornell.zoom.us/webinar/register/WN_nxNNOU7ITfOTppIuwsG_1g

IGNITE:Research Acceleration Webinar - Info Session 2
2021-04-16 12:00 - 13:00 UTC
IGNITE is Cornell Research’s next-generation funding program based on its original gap fund, the Cornell Technology Acceleration and Maturation (CTAM) Fund. The program provides up to $50,000 in grant funding to research labs. Projects are funded based on their alignment with the goals of the program.

During this virtual meeting, the team at CTL will provide information about the objectives of the program, the requirements to apply, and the selection process.

Register here:
https://cornell.zoom.us/meeting/register/tJcpc-GrrjosH9aZYhZYRESF11SlM5GK_7I2

More information about IGNITE:Research Acceleration:
https://ctl.cornell.edu/inventors/ignite-program/research-acceleration/

CTL IP Series #3: Software, Copyright, and Trademark
2021-04-22 12:00 - 13:00 UTC
The IP series is featuring invited guest speakers who will provide an overview of the different types of intellectual property (IP), updates on the latest changes in the IP landscape, and impact on strategies for protecting Cornell IP.

During this third series, Bill Pegg, Associate Director for IP at CTL will be joined by two IP Attorneys at Ryan, Mason & Lewis, LLP.

Speakers

Joseph B. Ryan, Partner, Ryan, Mason & Lewis, LLP
Patrick Murray, Associate, Ryan, Mason & Lewis, LLP

Register

https://cornell.zoom.us/meeting/register/tJIqf–uqD0vGdxL_mVVjSpx2uRYCxGxQXkk

Weill Digital Health Series #3: Securing Financing and the Founders Experience
2021-05-06 12:00 - 13:00 UTC
Investment in the U.S. digital health sector has significantly increased from $7.5B in 2019 to $14.1B in funding in 2020 [1]. With that number in mind, in the last session of the series, we bring together founders and investors to discuss the increased investors’ interest in digital health innovations, the investment opportunities, and the founders’ experience in this sector.

Speakers:

Katie Baker, Director Innovation – Digital Care Delivery, Anthem, Inc.
Michael Laskoff, Serial Entrepreneur; Founder, AbleTo, Inc.
Alex Morgan, Partner, Khosla Ventures

Asaf Zviran, CEO & CSO, C2i Genomics

Moderator:

Lisa Placanica, Senior Managing Director, Center for Technology Licensing at Weill Cornell Medicine (WCM)

Register

https://cornell.zoom.us/webinar/register/WN_gkf9xYXXS-mqYMlm20zHmw

University Technology Startup Series 1: Founder’s Equity & CEO Assessment
2021-05-20 12:30 - 13:30 (America/New_York)
Kirsten Leute and Margalit Haber at Osage University Partners (OUP) will provide an in-depth look at venture capital perspectives on the economics of university startup formation.

In the first part of the session, they will take the participants step-by-step through the life of a company, illustrating the uses of equity and potential outcomes for founders.

In the second part of the session, they will take the participants through the CEO search process, how VCs evaluate potential entrepreneurs, and some observations about drivers for long-term success as an entrepreneur. The participants will assess mock candidate profiles and learn methods of diligence to choose the right leader for their startup.

Speakers:

Kirsten Leute, Partner, University Relations, OUP
Margalit Haber, Associate – life science investment team, OUP

Register: https://cornell.zoom.us/meeting/register/tJIvc-yrpzIiGt0UblhVeLghYBwb59Npo97o

Silicon Catalyst / Cornell University Technology Showcase
2021-07-12 12:15 - 14:15 (America/New_York)
Building on their expanding collaboration to support university tech startups, Silicon Catalyst, the Center for Technology Licensing at Cornell University, and the Praxis Center for Venture Development are pleased to present their first Cornell University Technology Showcase. This all-virtual event will feature selected Cornell inventors delivering short presentations of their research technologies to explore commercialization opportunities. Live feedback and questions from the audience is encouraged during brief Q&A sessions following each presentation. Individual follow-up discussions with the researchers will be facilitated by the event organizers upon request.

Agenda
12:15pm – 12:30pm EDT
Introduction CTL & SiCa

12:30pm – 12:50pm EDT
Michal Lipson, Eugene Higgins Professor of Electrical Engineering and Professor of Applied Physics at Columbia University.
Topic: On-chip silicon photonics

12:50pm – 1:10pm EDT
Edward Suh, Professor, Electrical and Computer Engineering.
Topic: Hardware & embedded security; Memory encryption/verification

1:10pm – 1:30pm EDT
Edwin Kan, Professor, Electrical and Computer Engineering.
Topic: Passive RFID tags for locating and sensing

1:30pm – 1:50 pm EDT
Amit Lal, Robert M. Scharf 1977 Professor, Electrical and Computer Engineering.
Topic: Piezoelectric microsystems for inertial sensing

1:50pm – 2:10pm EDT
Deepdep Jena, David E. Burr Professor of Engineering, Electrical and Computer Engineering.
Topic: Photonic semiconductor and Ultra-wide bandgap devices

2:10pm – 2:15pm EDT
Conclusion

Register at https://cornell.zoom.us/meeting/register/tJIsfuquqTooE9ZmU68jqOXF8lDwCsyOA3Bi

CTL@WCM Practicum Information Session
2021-08-23 12:00 - 13:00 UTC
The Center for Technology Licensing at Weill Cornell Medicine (CTL@WCM), part of WCM Enterprise Innovation, is currently recruiting STEM and MBA graduate students affiliated with WCM to participate in the CTL@WCM Practicum. The CTL@WCM Practicum is a paid internship program that offers hands-on experience cultivating, marketing, and commercializing life science innovations. Participants will learn transferable skills for careers in academia, technology transfer, venture capital, consulting, and beyond. We are seeking candidates who are available to work with CTL@WCM for a minimum of 1 year at up to 10 hours per week.

Please join us on August 23, 2021, from 12-1pm EDT for an information session where we will discuss the application process, describe the program, and answer any questions you may have!
Register for the Info Session at https://cornell.zoom.us/meeting/register/tJEkd-qrpjIrH9zICVOQxH6baiFCZBZi4KB0

Applications are due September 10th, 2021: https://bit.ly/CTL-Practicum-Application

CTL Practicum – Info Session
2021-10-15 12:00 - 13:00, 2021-10-22 12:00 - 13:00 UTC
CTL Practicum is the internship program at the Center for Technology Licensing at Cornell University (CTL).
CTL, office responsible for commercializing research discoveries from Cornell researchers across the five campuses, is opening a new recruitment cycle of graduate students and post-doctoral researchers. The Practicum aims at providing valuable exposure to the process of commercialization.
During this session, students will learn about the program, about how their contribution impacts the activities at CTL, and about the benefits of this experiential learning program.
Will be discussed:
• The recruitment process and timeline,
• The eligibility criteria and requirements,
• The training sessions,
• The different types of assignments,
• Examples of career opportunities.
Come with your questions!
Presenter: Lynda Inséqué, Senior Program Manager, Technology Initiatives & Outreach
Learn more at https://ctl.cornell.edu/education/ctl-practicum/
Register at https://cornell.zoom.us/meeting/register/tJwod-qoqDMiH9GkPGmZ6pVcN-5ttPxB5lMI

CTL IP Series #1: Understanding the Technology Transfer Process
2021-10-26 12:00 - 13:00 UTC
The Center for Technology Licensing (CTL) is the office responsible for commercializing research discoveries from Cornell researchers across the five campuses at Cornell University.
In this series, CTL team will talk about what CTL does, will present the services provided to Cornell researchers and graduate students, and will provide an overview of the technology transfer process at Cornell.
Presenters:
• Lisa Placanica, Senior Managing Director, CTL@WCM
• Bill Pegg, Associate Director for IP, CTL
• Phil Owh, Associate Director, Licensing BD – Life sciences, CTL
• Martin Teschl, Associate Director, Licensing BD – Physical sciences, CTL
• Lynda Inséqué, Senior Program Manager, Technology Initiatives & Outreach, CTL
Learn more about CTL IP Series https://ctl.cornell.edu/ctl-ip-series/
Register at https://cornell.zoom.us/meeting/register/tJYvd-GrrTojGNOSgPOKiN2v6IYmCaiXpasd

UTS Series #2 - Pitching 101: How to Present Your Startups and Technology Innovation to Potential Funders
2021-11-02 12:00 - 13:00 UTC
For CTL second University Technology Startup (UTS) series, Margalit Haber and Ajay Rayasam at Osage University Partners (OUP) will focus the session on how an entrepreneur, or a faculty-entrepreneur can develop and deliver a pitch to gain interest and commitment from potential investors.
Pitching an early-stage science- and technology-based startup to potential funders can be intimidating. Learning how to tailor your presentation and understanding what motivates funders to say yes, or at least not give you an outright no, are important aspects of preparing for your initial pitch. This talk will be structured around OUP’s many years of experience in hearing pitches and reviewing pitch decks to provide insight on creating and presenting an initial startup pitch to funders.

Speakers:
Margalit Haber, PhD, Associate, Life Sciences, OUP
Ajay Rayasam, M.S., Associate, Technology, OUP

Register at https://cornell.zoom.us/meeting/register/tJAud-2pqzgoGNBJq_SmMtbViIiqdO6CEVyf

Ignite Innovation Acceleration - Fall Cycle Info Session #1
2021-11-15 12:00 - 12:45 UTC
Ignite Innovation Acceleration is one of the three signature programs of Ignite: Cornell Research Lab to Market gap funding series.
This Fall cycle is for applications from our research labs based on disclosed, active CTL inventions from Ithaca, Geneva or Cornell Tech campuses.
Applications are being accepted through December 10, 2021.
Join to learn more about the program series and the application process.

https://cornell.zoom.us/meeting/register/tJAoceqtrT4qG92o5N4SLqjZA-UCQJS01K2N

Ignite Innovation Acceleration - Fall Cycle Info Session #2
2021-11-19 12:00 - 12:45 UTC
Ignite Innovation Acceleration is one of the three signature programs of Ignite: Cornell Research Lab to Market gap funding series.
This Fall cycle is for applications from our research labs based on disclosed, active CTL inventions from Ithaca, Geneva or Cornell Tech campuses.
Applications are being accepted through December 10, 2021.
Join to learn more about the program series and the application process.

https://cornell.zoom.us/meeting/register/tJAldeuhrDgqHtH6vOzZc_szYyxVKvvPz5lU

Virtual Info Session - PHAR 9021 Fundamentals of Academic Business Development
2021-12-06 12:00 - 13:00 UTC
The Center for Technology Licensing at Weill Cornell Medicine (CTL@WCM), part of WCM Enterprise Innovation, is offering a new experiential course for graduate students seeking to learn about innovation management and academic business development.
PHAR 9021 will be held Spring 2022 and is designed to offer hands-on experience cultivating, marketing, and commercializing life science innovations. Participants will learn transferable skills for careers in academia, technology transfer, venture capital, consulting, and beyond. The course will be divided into three modules, each covering a specific aspect of the commercialization process: (I) Intellectual Property Protection, (II) Technology Evaluation, and (III) Partnering Academic Technologies. Each module, students will complete assignments that will directly support CTL@WCM and its mission to translate groundbreaking technologies into commercial products.
Course Prerequisites:

Enrolled in a Weill Cornell Medicine Graduate School PhD Program
Completion of the Admission to Doctoral Candidacy Examination (ACE)
Written approval of the applicant’s primary research advisor
PHAR 5009 01 Accelerating BioVenture Innovation (ABI)*

Course Details:

One Credit Course
Instructors will include CTL staff and external guest speakers
Initially offered in Spring 2022, from January 5th – April 27th
Lectures to be held every other Wednesday, 10am – 11:30am ET
Students will be evaluated on a Pass/Fail basis

* Students who haven’t completed PHAR 5009 but have completed equivalent coursework or have practical experience in academic innovation and entrepreneurship will be considered on a case-by-base basis

Contact: Jamie Brisbois (jamie.brisbois@cornell.edu) for additional information

Register: https://cornell.zoom.us/meeting/register/tJErfuCopzwoGdF7Pm-IdMSy6vpZZ9ePVKzF

Ignite Innovation Acceleration - 2021 Fall Cycle Presentations
2022-01-14 08:00 - 12:00 UTC
Innovation Acceleration applicants seeking gap funding, in the form of a $50,000 grant, present a summary of their proposal to the external selecting committee. Presentations highlight the technological innovation, anticipated Impact of project, and potential opportunities for future commercialization and follow-on investment.

CTL@WCM Office Hours with Lukasz Kowalik
2022-02-10
On February 10th, office hours will be hosted by Lukasz Kowalik, Senior Licensing and Business Development Officer at CTL@WCM.

Lukasz has a focus on CNS-related technologies:

Brain and Mind Research Institute
Metabolic Health Center
Meyer Cancer Center
Anesthesiology
Medicine
Neurological Surgery
Neurology
Psych
Qatar

To reserve your 30-minute Zoom office hours session, select your preferred date and time. You will be given access to a Zoom registration link and will meet privately with Lukasz within that Zoom session.

New Program: Ignite Postdoc for Ventures - Info Session 1
2022-02-11 12:00 - 13:00 UTC
Applications are now open for Ignite: Postdoc for Ventures program and accepted through April 4, 2022.

The Office of the Vice President for Research and Innovation (OVPRI) has launched Ignite Postdoc for Ventures, one of the three signature programs of the Ignite series to turn promising academic research into viable startups founded by Postdoctoral Fellows and soon-to-be graduating Ph.D. students.

The program will provide resources for entrepreneurial-minded postdocs to form new technology ventures based on Cornell inventions. The program adheres to a 1+1 model: 12-month phase in a Cornell lab, supervised by Cornell faculty, and 12-month phase in a business incubator, mentored by the incubator.

Key features of the program include:

Selected projects will be funded approximately $120K a year to support the compensation of the postdoc and basic experiment expenses
All Ignite Postdocs will be Cornell employees during both phases I and II of the program under full-time commitment
Postdocs will work at the faculty inventor’s lab for technology development and will have access to the incubator as an associate member for business development and connections during both phases
An Entrepreneur-in-Residence (EIR) will work closely with the Ignite Postdocs in both phases.

New Program: Ignite Postdoc for Ventures – Info Session 2
2022-02-16 12:00 - 13:00 UTC

IP Series #2: “Why are diagnostic claims so hard to get (in the US)?”
2022-02-17 12:00 - 13:00 UTC | Online Webinar
IP Series #2: “Why are diagnostic claims so hard to get (in the US)?”

Featured speakers:

Michael L. Goldman, Partner, Troutman Pepper
Tate Tischner, Counsel, Troutman Pepper
Brian Kelly, Director, Technology Licensing

During this second IP series, Mike Goldman, Tate Tischner, and Brian Kelly will address the challenges of protecting diagnostic innovations in the United States.

This talk will provide insights into the patent eligibility limitations in this field, the strategies to overcome them, and the important aspects to consider as an inventor when you disclose to the CTL office.

RSVP here.

A Plant License - AUTM Annual Conference
2022-02-23 10:30 - 10:45 UTC
The anatomy of a plant license is different from that of a biotechnology, pharmaceutical, or medical devices license. Different types of intellectual property protect plants, so drafting associated licenses can be challenging. The deal terms vary according to the type of license. Plants are a huge part of the earth’s ecosystem, and understanding how they grow and eventually reach the market is attractive. Panelists will cover these issues. Join this session, and you may even learn how the soybean made it to our dinner plates.

Moderator:
Jill Link, McKee, Voorhees & Sease, PLC
Speaker:
Thomas Herlache, MSU Technolgies
Brea Hutchcraft-May, Bayer Crop Science
Jessica Stein, Cornell University

CTL@WCM Office Hours with Donna Rounds
2022-03-10 14:00 - 16:00 UTC
CTL@WCM Virtual Office hours are open to all who wish to gain more information about the advancement of their patent filings, to discuss their technology venture project with a one-on-one meeting with a Weill Cornell Business Development and Licensing Officer. Book your 30-minute session in advance using the Bookings link below.

March 10th virtual office hours will be hosted by Donna J. Rounds, Interim Senior Technology Licensing Officer.

Donna has over 20 years of building value in early-stage life science technologies—from sourcing emergent technologies to developing strategies for commercialization. She specializes in managing complex scientific and business relationships and leveraging the synergy of cross-functional teams in due diligence and technology assessments, prototype development, and proof-of-concept studies. She has a strong track record in successful outcomes through negotiation and transactions for licensing, sponsored research, and the creation of strategic alliances in pharma, biotech, and academia. Her passion is launching innovative projects into next-generation health and wellness care products.

Schedule online

Social Science Innovation Series #1: Virtual Fireside Chat with Professor Peter Enns
2022-03-10 16:00 - 17:00 UTC
Have you ever had an idea for turning the knowledge gained from your research into a business or a non-profit, but wondered how to do It? Come join us for a series of conversations about how we can use social science innovation to help find solutions to the toughest challenges in society. We’ll help you explore and understand the possible paths and available Cornell structures to support your applications of innovation from academia research to improve cultural, financial, environmental, social sustainability while achieving social impact, and perhaps financial return.

This three-part Social Science Innovation Series in the spring semester of 2022 will engage in the exploration of opportunities offered in this thought-provoking field.

For the first session, we will hear from Professor Peter Enns, the Robert S. Harrison Director of the Cornell Center for Social Sciences and co-founder of Verasight, in a virtual fireside chat about the experience and the lessons learned about applying his research in real world for social and business impact.

Our host will be Alice Li, Executive Director at the Center for Technology Licensing.

Join us to learn from Cornell peer experience! Register here.

About Professor Peter Enns

Peter K. Enns is a Professor in the Department of Government and the Brooks School of Public Policy, Robert S. Harrison Director of the Cornell Center for Social Sciences, and Executive Director of the Roper Center for Public Opinion Research. He is also co-founder and chief data scientist at Verasight. His research and teaching focus on public opinion and political representation, mass incarceration and the legal system, and data science.
Enns has published three books—Hijacking the Agenda: Economic Power and Political Influence, Incarceration Nation: How the United States Became the Most Punitive Democracy in the World, and Who Gets Represented?—and dozens of academic articles and op-eds. His research has been funded by the Economic and Social Research Council, FWD.us, Koch Foundation, National Science Foundation, Robert Wood Johnson Foundation, and Russell Sage Foundation. In 2017, he received the Emerging Scholar Award from the Elections, Public Opinion, and Voting Behavior section of the American Political Science Association, presented to the top scholar in the field within ten years of her or his doctorate.

CTL@WCM Special Panel on Women's Health
2022-03-17 12:00 - 13:00 UTC
From reproductive health menopause to mental health, more attention is being paid to women’s health issues as they are becoming less taboo. As of 2021, the women’s health segment accounts for only 4% of R&D funding and only 1.4% of capital invested in healthcare [1]; however, it is one of the fastest-growing segments in the healthcare industry. The field is mainly driven by innovation in digital health and surgical innovations.

In a special panel, CTL@WCM will address the opportunities in the field with the lens of commercialization and venture creation. Our guest panelists will provide insight as we explore the trends in women’s health, the emergence of women-led companies, and the role of women founders.

Panelists

Tamatha Fenster, Assistant Professor of Clinical Obstetrics and Gynecology, Obstetrics and Gynecology, Weill Cornell Medicine
Sabrina Johnson, President and CEO, Daré bioscience
Vrunda Desai, Global Head of Medical Affairs, CooperSurgical, and Assistant Professor, Adjunct, in Obstetrics, Gynecology and Reproductive Sciences at Yale University School of Medicine.
Maria Velissaris, Founding Partner at SteelSky Ventures

[1] FemTech Industry 2021: Landscape Overview

Ignite Innovation Acceleration – 2022 Spring Cycle Info Session #1
2022-03-25 12:00 - 13:00 UTC
Ignite Innovation Acceleration is a gap funding program and one of the three signature programs of Ignite: Cornell Research Lab to Market gap funding series. The program aims to advance Cornell University research innovations to the next inflection point (technical or commercial validation) towards commercialization.
Awarded projects receive up to $50,000. Funding is provided in form of grants to labs to advance inventions toward licensing, startup formation, or industry partnerships.
Project applications are submitted by Cornell University research labs based on disclosed, active CTL inventions from Ithaca, Geneva, or Cornell Tech campuses.
Applications are being accepted through April 18, 2022.
Join the information session to learn more about the program series and the application process.

Ignite Innovation Acceleration – 2022 Spring Cycle Info Session #2
2022-04-08 12:00 - 13:00 UTC

CTL@WCM Office Hours with Brian Kelly
2022-04-14 14:00 - 16:00 UTC
CTL@WCM Virtual Office hours are open to all who wish to gain more information about the advancement of their patent filings. You will discuss technology venture projects in a one-on-one meeting with a Weill Cornell Business Development and Licensing Officer. Book your 30-minute session in advance using the Bookings link below.

April 14th office hours will be hosted by Brian Kelly, the Director of Technology Licensing at CTL, NYC office.

Brian manages a portfolio of inventions focusing on oncology, metabolic diseases, and endocrine disorders. Brian has primary responsibility for Biochemistry, Genetic Medicine, Pharmacology, Institute for IBD, and Dermatology. Register here.

IP Series #3: Successful Patent Applications--It’s All in the Timing
2022-04-20 12:00 - 13:00 UTC
The right to be granted a patent for a given invention lies with the first person to file a fully-supported patent application. However, rushing to the patent office does not necessarily lead to the best outcomes in patenting. Finding the perfect time to file a patent is a collaborative process between the inventor and CTL, discovering a time that is not too early or too late. In this third session of the IP Series, we will discuss real-life examples of practical considerations in invention disclosure timing, including enablement, written description, and prior art hazards in publishing scientific findings before patenting. Join us to consider the status of your research and successful timing.

Featuring:
Paul J. Roman, J.D., Ph.D. Partner, Johnson, Marcou, Issacs & Nix, LLC.
Carin R. Miller, J.D., Ph.D. Associate, Johnson, Marcou, Issacs & Nix, LLC.

Register here.

CTL@WCM Office Hours with Brian Kelly
2022-04-28 14:00 - 16:00 UTC
CTL@WCM Virtual Office hours are open to all who wish to gain more information about the advancement of their patent filings. You will discuss technology venture projects in a one-on-one meeting with a Weill Cornell Business Development and Licensing Officer. Book your 30-minute session in advance using the Bookings link below.

April 128th office hours will be hosted by Brian Kelly, the Director of Technology Licensing at CTL, NYC office.

Brian manages a portfolio of inventions focusing on oncology, metabolic diseases, and endocrine disorders. Brian has primary responsibility for Biochemistry, Genetic Medicine, Pharmacology, Institute for IBD, and Dermatology. Register here.

CTL@WCM Special Panel on Drug Repurposing
2022-05-24 13:00 - 14:00 UTC
Can you teach an old drug new tricks? Recent successes in repositioning existing drugs – from esketamine for treatment-resistant depression to remdesivir – originally developed to treat hepatitis C, tested for Ebola before being approved as a treatment for COVID 19 – point to potential upsides. The challenges, however, are many: from challenging IP prospects to skeptical investors. We have assembled an expert panel to discuss with us the enticing shortcuts repurposing may offer, the pitfalls it brings, and how to develop strategies to overcome them.
Join us at the second virtual CTL@WCM Special Panel, where innovators, IP experts, and regulators gather to assess the landscape and talk about the opportunities.
Featured panelists:

Dr. Bruce Bloom, Chief Collaboration Officer, Healx
Eyal Barash, J.D., M.S, Founder of Barash Law
Valentyna Chebanova, Sr. Manager of Business Development at Tarsus Pharmaceuticals

Moderated by Lisa Placanica, Senior Managing Director, Center for Technology Licensing at Weill Cornell Medicine

Register here.
